SCHEMBL7974983

SCHEMBL7974983

CCn1c2ccccc2c2cc(NC(=O)NC(C)c3ccccc3)ccc21

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.67
LMNA P02545 3/20 0.67
NPSR1 Q6W5P4 2/20 0.65
RORC P51449 4/20 0.64
NPY2R P49146 1/20 0.63
KDM4E B2RXH2 5/20 0.62
MEN1 O00255 4/20 0.62
KMT2A Q03164 4/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
ALDH1A1 P00352 3/20 0.62
HPGD P15428 3/20 0.62
GAA P10253 1/20 0.62
NPY5R Q15761 3/20 0.60
POLB P06746 1/20 0.57
MAPK1 P28482 1/20 0.57
BLM P54132 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
PTGES O14684 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4727375 0.88 MAPT (0.73) MAPTLMNANPSR1RORCNPY2R
SCHEMBL1593538 0.84 MAPT (0.69) MAPTLMNANPSR1RORCNPY2R
SCHEMBL1593536 0.84 MAPT (0.69) MAPTLMNANPSR1RORCNPY2R
SCHEMBL7974078 0.81 MAPT (1.00) MAPTLMNANPSR1RORCNPY2R
SCHEMBL7722815 0.79 NPSR1 (1.00) MAPTLMNANPSR1RORCKDM4E
SCHEMBL4728828 0.79 NPSR1 (0.70) MAPTLMNANPSR1RORCKDM4E
SCHEMBL7976971 0.79 MAPT (0.71) MAPTLMNANPSR1RORCKDM4E
SCHEMBL7722872 0.78 MAPT (0.75) MAPTLMNANPSR1KDM4EMEN1
SCHEMBL7977193 0.78 NPSR1 (0.78) MAPTLMNANPSR1RORCKDM4E
SCHEMBL14199692 0.78 MAPT (0.82) MAPTLMNANPSR1RORCKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001007409-A1 CARBAZOLE DERIVATIVES AND THEIR USE AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS ASTRAZENECA UK LIMITED (GB) 2001-02-01 WO disclosed